Alex Thompson
Stock Analyst at Stifel
(1.65)
# 3,108
Out of 4,711 analysts
30
Total ratings
45.83%
Success rate
-6.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alex Thompson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Maintains: Buy | $200 → $207 | $136.38 | +51.78% | 2 | Nov 15, 2024 | |
| ORKA Oruka Therapeutics | Initiates: Buy | $49 | $20.31 | +141.26% | 1 | Oct 11, 2024 | |
| ARGX argenx SE | Maintains: Buy | $485 → $500 | $623.82 | -19.85% | 4 | Jun 24, 2024 | |
| THRD Third Harmonic Bio | Initiates: Buy | $23 | $10.84 | +112.18% | 1 | Jun 18, 2024 | |
| SYRE Spyre Therapeutics | Reiterates: Buy | $36 → $54 | $23.86 | +126.32% | 2 | Mar 26, 2024 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $44 | $23.80 | +84.87% | 1 | Feb 15, 2024 | |
| VTYX Ventyx Biosciences | Maintains: Hold | $6 → $2 | $2.24 | -10.71% | 5 | Dec 18, 2023 | |
| TVTX Travere Therapeutics | Maintains: Hold | $8 → $10 | $17.18 | -41.79% | 2 | Dec 18, 2023 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $66 → $69 | $52.17 | +32.26% | 2 | Dec 18, 2023 | |
| ACRS Aclaris Therapeutics | Maintains: Hold | $2 → $1 | $2.72 | -63.24% | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $19.03 | +110.19% | 2 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $0.83 | +4,746.14% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $34 | $25.86 | +31.48% | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $13.21 | +149.81% | 1 | Dec 14, 2022 |
Ascendis Pharma
Nov 15, 2024
Maintains: Buy
Price Target: $200 → $207
Current: $136.38
Upside: +51.78%
Oruka Therapeutics
Oct 11, 2024
Initiates: Buy
Price Target: $49
Current: $20.31
Upside: +141.26%
argenx SE
Jun 24, 2024
Maintains: Buy
Price Target: $485 → $500
Current: $623.82
Upside: -19.85%
Third Harmonic Bio
Jun 18, 2024
Initiates: Buy
Price Target: $23
Current: $10.84
Upside: +112.18%
Spyre Therapeutics
Mar 26, 2024
Reiterates: Buy
Price Target: $36 → $54
Current: $23.86
Upside: +126.32%
Dianthus Therapeutics
Feb 15, 2024
Initiates: Buy
Price Target: $44
Current: $23.80
Upside: +84.87%
Ventyx Biosciences
Dec 18, 2023
Maintains: Hold
Price Target: $6 → $2
Current: $2.24
Upside: -10.71%
Travere Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $8 → $10
Current: $17.18
Upside: -41.79%
MoonLake Immunotherapeutics
Dec 18, 2023
Maintains: Buy
Price Target: $66 → $69
Current: $52.17
Upside: +32.26%
Aclaris Therapeutics
Dec 18, 2023
Maintains: Hold
Price Target: $2 → $1
Current: $2.72
Upside: -63.24%
Sep 13, 2023
Reiterates: Buy
Price Target: $40
Current: $19.03
Upside: +110.19%
Aug 9, 2023
Initiates: Buy
Price Target: $40
Current: $0.83
Upside: +4,746.14%
Jul 18, 2023
Maintains: Buy
Price Target: $28 → $34
Current: $25.86
Upside: +31.48%
Dec 14, 2022
Initiates: Buy
Price Target: $33
Current: $13.21
Upside: +149.81%